Edition:
United States

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

12.29USD
26 May 2017
Change (% chg)

$0.63 (+5.40%)
Prev Close
$11.66
Open
$11.78
Day's High
$12.35
Day's Low
$11.78
Volume
240,189
Avg. Vol
221,081
52-wk High
$12.40
52-wk Low
$4.95

CORT.OQ

Chart for CORT.OQ

About

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)

Overall

Beta: 2.08
Market Cap(Mil.): $1,319.77
Shares Outstanding(Mil.): 113.19
Dividend: --
Yield (%): --

Financials

  CORT.OQ Industry Sector
P/E (TTM): 110.53 14.31 17.43
EPS (TTM): 0.11 -- --
ROI: 31.98 -7.26 -5.41
ROE: 35.98 -6.76 -4.69

BRIEF-Corcept therapeutics Q1 GAAP earnings per share $0.04

* Corcept Therapeutics announces first quarter 2017 financial results, raises 2017 revenue guidance and provides corporate update

May 01 2017

BRIEF-Corcept Therapeutics files for mixed shelf of up to $200 mln

* In addition, 349,425 shares of co's common stock offered by the selling stockholders

Mar 13 2017

BRIEF-Corcept Therapeutics posts Q4 earnings per share $0.04

* Corcept Therapeutics announces fourth quarter and full-year 2016 financial results; increases 2017 revenue guidance

Mar 06 2017

BRIEF-Corcept Therapeutics reports Q4 preliminary GAAP earnings per share $0.04

* Corcept Therapeutics announces preliminary fourth quarter and full-year 2016 financial results and corporate update; provides 2017 revenue guidance

Jan 30 2017

More From Around the Web

Competitors

Earnings vs. Estimates